Quarterly report pursuant to Section 13 or 15(d)

Description of Business and Summary of Significant Accounting Policies (Tables)

v3.24.1.u1
Description of Business and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2024
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash The following is a summary of cash, cash equivalents and restricted cash at March 31, 2024 and December 31, 2023:
(in thousands)   March 31,
2024		     December 31,
2023		  
Cash and cash equivalents   $ 84,057     $ 76,677  
Restricted cash – long-term     316       313  
Cash, cash equivalents and restricted cash   $ 84,373     $ 76,990  
Schedule of Computation of Diluted Net Loss Per Share For the three months ended March 31, 2024 and 2023, the Company’s potentially dilutive shares, which include outstanding common stock options, restricted stock units and warrants, have not been included in the computation of diluted net loss per share as the result would have been anti-dilutive.
(in thousands)   March 31,
2024		     March 31,
2023		  
Stock Options     5,421       3,324  
Restricted Stock Units     305       325  
Warrants     1,439       1,443  
Total     7,165       5,092